Lee Pharmaceuticals, Inc.
AIMN
$0.01
$0.00-36.36%
OTC PK
| 06/30/2022 | 03/31/2022 | ||||
|---|---|---|---|---|---|
| Net Income | -277.60K | -277.60K | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | 45.70K | 45.70K | |||
| Total Other Non-Cash Items | 129.20K | 129.20K | |||
| Change in Net Operating Assets | 6.60K | 6.60K | |||
| Cash from Operations | -96.20K | -96.20K | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | 246.80K | 246.80K | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -144.00K | -144.00K | |||
| Cash from Financing | 102.80K | 102.80K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 6.60K | 6.60K | |||